What’s New

Latest News

Conference Coverage
First-Line Nivolumab Plus Ipilimumab for Patients With Unresectable Hepatocellular Carcinoma: CheckMate 9DW 4-Year Follow-Up
01/12/2026
Stephanie Holland
Updated results from the phase 3 CheckMate 9DW trial show that first-line nivolumab plus ipilimumab continues to demonstrate sustained clinical efficacy with a manageable safety profile among patients with unresectable hepatocellular...
Updated results from the phase 3 CheckMate 9DW trial show that first-line nivolumab plus ipilimumab continues to demonstrate sustained clinical efficacy with a manageable safety profile among patients with unresectable hepatocellular...
Updated results from the phase 3...
01/12/2026
Oncology
Oncology
illustration of a brain
News
Meta-Analysis Confirms Processing Speed as Core Cognitive Deficit in Schizophrenia
01/12/2026
Maria Mantas
Processing speed remains one of the most severely impaired cognitive domains in people with schizophrenia, according to a large systematic review and meta-analysis published in JAMA Psychiatry.
Processing speed remains one of the most severely impaired cognitive domains in people with schizophrenia, according to a large systematic review and meta-analysis published in JAMA Psychiatry.
Processing speed remains one of...
01/12/2026
Psych Congress Network
Psych Congress Network
News
2025 US Cancer Disparities Report Highlights Education, Rural Gaps
01/12/2026
Hannah Musick
The American Cancer Society’s 2025 report reveals that education level and rural residence drive larger US cancer mortality disparities than race alone, underscoring the central role of socioeconomic and geographic inequities across the...
The American Cancer Society’s 2025 report reveals that education level and rural residence drive larger US cancer mortality disparities than race alone, underscoring the central role of socioeconomic and geographic inequities across the...
The American Cancer Society’s...
01/12/2026
Journal of Clinical Pathways
Journal of Clinical Pathways
News
Specialist Access Eliminates Racial Gaps in Rheumatoid Arthritis DMARD Use
01/12/2026
Lisa Kuhns, PhD, MD
Racial inequities in access to modern rheumatoid arthritis (RA) therapies persist across the United States, but disappear among patients who reach rheumatology care, according to study results published in The Journal of Rheumatology.
Racial inequities in access to modern rheumatoid arthritis (RA) therapies persist across the United States, but disappear among patients who reach rheumatology care, according to study results published in The Journal of Rheumatology.
Racial inequities in access to...
01/12/2026
First Report Managed Care
First Report Managed Care
News
Johnson & Johnson Reaches US Drug Pricing Agreement With Trump Administration
01/09/2026
Grace Taylor, MS, MA
Johnson & Johnson has struck a voluntary agreement with the Trump Administration to lower US drug prices, expand patient access, and accelerate billions in domestic pharmaceutical manufacturing investments.
Johnson & Johnson has struck a voluntary agreement with the Trump Administration to lower US drug prices, expand patient access, and accelerate billions in domestic pharmaceutical manufacturing investments.
Johnson & Johnson has struck a...
01/09/2026
Integrated Healthcare Executive
Integrated Healthcare Executive
detroit paramedic class 1
News
Detroit Fire Department Celebrates Graduation of First Department-Run Paramedic Class
01/09/2026
28 members completed the program, expanding advanced life support capabilities citywide in partnership with Wayne County Community College District.
28 members completed the program, expanding advanced life support capabilities citywide in partnership with Wayne County Community College District.
28 members completed the...
01/09/2026
EMSWorld
EMSWorld
PharmLaw
Jefferson Health Alleges Insulin Rebate Scheme Between PBMs and Drugmakers
01/09/2026
Juliet Gallagher
A major nonprofit health system has filed a federal lawsuit accusing leading insulin manufacturers and pharmacy benefit managers (PBMs) of conspiring to inflate insulin prices through rebate-driven pricing practices that allegedly harm...
A major nonprofit health system has filed a federal lawsuit accusing leading insulin manufacturers and pharmacy benefit managers (PBMs) of conspiring to inflate insulin prices through rebate-driven pricing practices that allegedly harm...
A major nonprofit health system...
01/09/2026
Pharmacy Learning Network
Pharmacy Learning Network

Latest Research

Podiatry Today December 2025
Podiatry Today
Podiatry Today Shaping Podiatric Practice: 25 Years of Progress
Vol. 38, Issue 12, Issue January 2026

HMP Global Learning Network

Featured Interviews

Alison Schram, MD, Memorial Sloan Kettering Cancer Center
Videos
Treating NRG1 Fusion-Positive Non-Small Cell Lung Cancer
01/02/2026
Alison Schram, MD
Alison Schram, MD, discusses the treatment course taken for a case of a patient with non-small cell lung cancer with a CD74-NRG1 gene fusion.
Alison Schram, MD, discusses the treatment course taken for a case of a patient with non-small cell lung cancer with a CD74-NRG1 gene fusion.
Alison Schram, MD, discusses the...
01/02/2026
Oncology
Matthew Regulski, DPM, FFPM, RCPS (Glasgow), DABMSP
Viewpoints
Cutting Costs, Raising Standards: The Case for Evidence-Based CTP Use
12/30/2025
Matthew J. Regulski, DPM, ABMSP, CMET, FAPWH(c)
CMS reimbursement reforms are reshaping the use of skin substitutes in wound care, phasing out high-cost, low-evidence products in favor of therapies backed by rigorous clinical data. New models like WISeR promote prior authorization to...
CMS reimbursement reforms are reshaping the use of skin substitutes in wound care, phasing out high-cost, low-evidence products in favor of therapies backed by rigorous clinical data. New models like WISeR promote prior authorization to...
CMS reimbursement reforms are...
12/30/2025
Wounds
Michael Kappelman
From the AIBD Open Air Studio
The Sherman Prize: Michael Kappelman, MD
12/29/2025
Michael Kappelman, MD
Dr Michael Kappelman, one of the Sherman Prize winners for 2025, speaks from the Open Air Studio at the Advances in IBD meeting about his clinical and research work with pediatric patients with ulcerative colitis or Crohn's disease.
Dr Michael Kappelman, one of the Sherman Prize winners for 2025, speaks from the Open Air Studio at the Advances in IBD meeting about his clinical and research work with pediatric patients with ulcerative colitis or Crohn's disease.
Dr Michael Kappelman, one of the...
12/29/2025
Advances in Inflammatory Bowel Disease Network
CTP News Desk Image
Viewpoints
Observations on Potential Pivots and Continued Change
12/01/2025
Scott Nelson
This speaker expounds on potential trends he sees for CTPs in 2026.
This speaker expounds on potential trends he sees for CTPs in 2026.
This speaker expounds on...
12/01/2025
Wounds
Corey Siegel
Conference Coverage
Corey Siegel, MD, on Improving IBD Care Models
11/28/2025
Corey A. Siegel, MD, MS
In the J Edward Burke Distinguished Lecture at the ACG Scientific Meeting, Dr Corey Siegel outlined 5 problems in advancing the care of patients with inflammatory bowel disease, and discussed how the RADIUS program begun at his institution...
In the J Edward Burke Distinguished Lecture at the ACG Scientific Meeting, Dr Corey Siegel outlined 5 problems in advancing the care of patients with inflammatory bowel disease, and discussed how the RADIUS program begun at his institution...
In the J Edward Burke...
11/28/2025
Advances in Inflammatory Bowel Disease Network
BDHC thumbnail
Videos
Breaking Down Cancer Prevention: What Really Works?
11/26/2025
John Hennessy, MBA; Michael Kolodziej, MD
In this episode of Breaking Down Health Care, John Hennessy and Dr. Michael Kolodziej explore the crucial difference between cancer screening and true cancer prevention, highlighting how lifestyle changes, vaccines, and emerging therapies...
In this episode of Breaking Down Health Care, John Hennessy and Dr. Michael Kolodziej explore the crucial difference between cancer screening and true cancer prevention, highlighting how lifestyle changes, vaccines, and emerging therapies...
In this episode of Breaking Down...
11/26/2025
Cancer Care Business Exchange
Part 3
Videos
Part 3: Rebuilding Confidence: Multidisciplinary and Holistic Approaches to Severe Alopecia Areata
11/03/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
In the final installment of this expert roundtable series, top dermatologists discuss holistic care in alopecia areata, including emotional support, patient education, and resources like the National Alopecia Areata Foundation. Learn how to...
In the final installment of this expert roundtable series, top dermatologists discuss holistic care in alopecia areata, including emotional support, patient education, and resources like the National Alopecia Areata Foundation. Learn how to...
In the final installment of this...
11/03/2025
The Dermatologist
Dr Desai
Sponsored Video
Nimesh Desai, MD, Shares His Perspective on Recently Published 5-Year Outcomes in Acute Complicated Type B Aortic Dissection
11/01/2025
Nimesh Desai, MD, PhD
Dr Desai shares his perspective on the key long-term outcomes of the US IDE Clinical Trial, Type B Dissection.
Dr Desai shares his perspective on the key long-term outcomes of the US IDE Clinical Trial, Type B Dissection.
Dr Desai shares his perspective...
11/01/2025
Vascular Disease Management
Koulopoulos
Videos
Gigatrends Reshaping Global Health Care: Insights for CPC+CBEx 2025
10/31/2025
Thomas Koulopoulos
Futurist Thomas Koulopoulos explores how “gigatrends”—seismic global shifts like changing demographics and AI—are redefining health care, urging a balance between innovation and trust as the industry evolves toward more human-centered,...
Futurist Thomas Koulopoulos explores how “gigatrends”—seismic global shifts like changing demographics and AI—are redefining health care, urging a balance between innovation and trust as the industry evolves toward more human-centered,...
Futurist Thomas Koulopoulos...
10/31/2025
Journal of Clinical Pathways
Srikala Sridhar, MD
Videos
Avelumab Shows Durable Response in Advanced Penile Cancer
10/31/2025
Srikala Sridhar, MD
Srikala Sridhar, MD, discusses results from the phase 2 ALPACA study evaluating avelumab in patients with locally advanced or metastatic penile cancer who were unfit for or experienced disease progression after platinum-based chemotherapy.
Srikala Sridhar, MD, discusses results from the phase 2 ALPACA study evaluating avelumab in patients with locally advanced or metastatic penile cancer who were unfit for or experienced disease progression after platinum-based chemotherapy.
Srikala Sridhar, MD, discusses...
10/31/2025
Oncology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use